United States · Startup

Bell Biosystems

Bell Biosystems, a research-stage biotechnology company, develops tools that accelerate innovations in oncology and cell therapy research.

Funding reportedLast round: Series A

Berkeley, United States

Follow Bell Biosystems and see its new rounds in your feed. Start following

What company datasets say Bell Biosystems raised

Funding, as reported

Reported in all$9.1Min dollars

Rounds3

Last roundSeries A

Last round size$3.8M

Last round dateApr 2015

Investors listed3

SEC Form D$6.2M sold, 4 filings, last Apr 2015

Bell Biosystems filed 3 raises, $4.2M in all. Filings say how much was sold and to how many investors; they never name the investors.

Dec 2013$3.8M25 investorsequitySEC Form D
May 2012$250K3 investorsequity, debt, options, securities on exerciseof $2.0M offeredSEC Form D
Jun 2011$120K9 investorsequity, debt, options, securities on exerciseSEC Form D

From the SEC filings it signed: 1 on the team.

On the board, as filediChristian B. OlgaardGil B. Van BokkelenStuart B. BermanUna B. Ryan

Investors who name them

Each firm lists Bell Biosystems on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

What they build

Built with from their website

Amazon AWS

Add your raise, your deck and your story, and put Bell Biosystems in front of investors. Or tell us what we have wrong.